Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Trial: Swallowing Speech Pathology Intervention During Radiochemotherapy on Patients With Head and Neck Cancer

NCT02075385 is registered in ClinicalTrials.gov with Barretos Cancer Hospital as lead sponsor.

NCT NCT02075385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02075385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Trial: Swallowing Speech Pathology Intervention During Radiochemotherapy on Patients With Head and Neck Cancer
Lead sponsor
Barretos Cancer Hospital
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2012
Completion date
August 31, 2015
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head neck cancer, swallowing disorders